Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Acq. announced
Quarterly results

PTC THERAPEUTICS, INC. (PTCT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 8-K Quarterly results
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
07/19/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
07/17/2023 4 Gravier Pierre (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 26,000 shares @ $0
Granted 65,000 options to buy @ $39.82, valued at $2.6M
07/17/2023 3 Gravier Pierre (CFO) has filed a Form 3 on PTC THERAPEUTICS, INC.
07/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/09/2023 4 SCHMERTZLER MICHAEL (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 1,000 shares @ $44.86, valued at $44.9k
06/07/2023 4 Bell William F. Jr. (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 4,000 shares @ $0
Granted 2,333 shares @ $0
Granted 10,000 options to buy @ $45.015, valued at $450.2k
Granted 5,834 options to buy @ $45.015, valued at $262.6k
06/07/2023 3 Bell William F. Jr. (Director) has filed a Form 3 on PTC THERAPEUTICS, INC.
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/06/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
05/24/2023 4 Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 173 shares @ $59.5242, valued at $10.3k
Sold 2,995 shares @ $59.5335, valued at $178.3k
Sold 3,948 shares @ $59.5313, valued at $235k
Sold 157 shares @ $59.5171, valued at $9.3k
Sold 1,093 shares @ $59.532, valued at $65.1k
Sold 1,402 shares @ $59.5378, valued at $83.5k
Exercised 173 options to buy @ $33.63, valued at $5.8k
Exercised 2,995 options to buy @ $33.02, valued at $98.9k
Exercised 3,948 options to buy @ $33.63, valued at $132.8k
Exercised 157 options to buy @ $33.63, valued at $5.3k
Exercised 1,093 options to buy @ $33.02, valued at $36.1k
05/23/2023 144 Form 144 - Report of proposed sale of securities:
05/23/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "PTC Therapeutics Announces Strategic Pipeline Prioritization",
"PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial",
"62 61 123 73 70 143"
05/23/2023 4 Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 6,403 shares @ $58.9553, valued at $377.5k
Sold 1,913 shares @ $58.9783, valued at $112.8k
Sold 100 shares @ $59.66, valued at $6k
05/19/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 4 Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 800 shares @ $58.5175, valued at $46.8k
Sold 7,248 shares @ $58.5, valued at $424k
Sold 788 shares @ $58.7143, valued at $46.3k
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 D Form D - Notice of Exempt Offering of Securities:
05/05/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
04/28/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
04/27/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 8-K Quarterly results
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 144 Form 144 - Report of proposed sale of securities:
04/21/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy